Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0182L2 |
(±) Clopidogrel hydrogen sulfate
硫酸氢氯吡格雷,Plavix,Clopidogrel hydrogen sulfate,Iscover |
P2Y Receptor | GPCR/G Protein; Neuroscience |
(±) Clopidogrel hydrogen sulfate (Iscover) 是一种在药理学和结构上类似于ticlopidine 的抗血小板药物,用于抑制脑血管疾病、外周血管疾病和冠状动脉疾病等各种疾病中的血栓。 | |||
T71254 |
Clopidogrel HCl
|
||
Clopidogrel HCl is the salt form of Clopidogrel (free base), an inhibitor of ADP-induced platelet aggregation acting by direct inhibition of adenosine diphosphate (ADP) binding to its receptor and of the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. | |||
T0182 |
Clopidogrel
(S)-Clopidogrel,SR-25990C,氯吡格雷 |
P2Y Receptor | GPCR/G Protein; Neuroscience |
Clopidogrel (SR-25990C) 是一种 P2Y12 受体拮抗剂,可降低血小板聚集,用于抑制冠状动脉疾病、周围血管疾病和脑血管疾病中的血凝块。 | |||
T35431 |
(±)-Clopidogrel (hydrochloride)
|
||
Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation ex vivo and functions as a prodrug whereupon biotransformation to its active metabolite via CYP2C19 in the liver enables its anti-aggregating activity. Marketed under the name Plavix , clopidogrel in combination with aspirin has been shown to be beneficial in the prevention of vascu... |